Partial splenic embolization for hypersplenism in cirrhosis: A long-term outcome in 62 patients

被引:88
|
作者
Zhu, K. [1 ]
Meng, X. [1 ]
Qian, J. [1 ]
Huang, M. [1 ]
Li, Z. [1 ]
Guan, S. [1 ]
Jiang, Z. [1 ]
Shan, H. [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Radiol, Guangzhou 510630, Guangdong, Peoples R China
关键词
Cirrhosis; Hypersplenism; Long-term outcome; Partial splenic embolization; LIVER-CIRRHOSIS; ARTERIAL EMBOLIZATION; COMPLICATIONS; THROMBOCYTOPENIA; SPLENECTOMY; THERAPY;
D O I
10.1016/j.dld.2008.10.005
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Although partial splenic embolization (PSE) has been widely used for treatment of leucocytopaenia and thrombocytopaenia in cirrhosis, only few studies on the correlation between splenic infarction rate and long-term outcome of partial splenic embolization have been reported so far. Aim. To evaluate long-term results of partial splenic embolization with different infarction rates in cirrhotic patients with hypersplenism. Methods. Sixty-two consecutive patients with hypersplenism in cirrhosis received partial splenic embolization. According to the splenic infarction rate after partial splenic embolization, the patients were divided into three groups: more than 70% in group A (n = 12), 50-70% in group B (n = 34), and less than 50% in group C (n = 16). The post-partial splenic embolization following-up time was 5 years. Results. Before partial splenic embolization, there were no significant differences among the three groups with respect to sex, age, splenic Volume, Child-Pugh class, oesophageal varices, and peripheral blood cell Counts. After partial splenic embolization, the short- and long-term Outcomes of leucocyte and platelet counts showed significant difference among the three groups (P<0.001). In groups A and B, the leucocyte and platelet counts after partial splenic embolization remained significantly higher than those before partial splenic embolization for 2 weeks to 5 years (P<0.05), the post-partial splenic embolization leucocyte and platelet counts was even higher in group A than in group 13 while in group C, leucocyte and platelet count improvement only lasted for 6 months after partial splenic embolization. No significant changes were observed concerning blood red cell counts and liver function parameters after partial splenic embolization among the three groups. Severe complications occurred in six patients (50%) in group A and three patients (8.8%) in group B (P<0.05). while in group C, no severe complications developed. Conclusions. In partial splenic embolization, the splenic infarction rate should be limited to 50%-70% in order to ensure the long-term efficacy in alleviating hypersplenism and reduce complications. (C) 2008 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:411 / 416
页数:6
相关论文
共 50 条
  • [1] Long-term evaluation of partial splenic embolization for liver cirrhosis and hepatocellular carcinoma accompanied by hypersplenism
    Ohmoto, K
    Iguchi, Y
    Miyake, I
    Ohno, S
    Yamamoto, S
    [J]. HEPATOLOGY RESEARCH, 1998, 11 (02) : 73 - 83
  • [2] Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients
    N'Kontchou, G
    Seror, O
    Bourcier, V
    Mohand, D
    Ajavon, Y
    Castera, L
    Grando-Lemaire, V
    Ganne-Carrie, N
    Sellier, N
    Trinchet, JC
    Beaugrand, M
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (02) : 179 - 184
  • [3] Partial splenic embolization: long-term outcome
    Birger Pålsson
    Magnus Hallén
    Annika Mandahl Forsberg
    Anders Alwmark
    [J]. Langenbeck's Archives of Surgery, 2003, 387 : 421 - 426
  • [4] Partial splenic embolization:: long-term outcome
    Pålsson, B
    Hallén, M
    Forsberg, AM
    Alwmark, A
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 2003, 387 (11-12) : 421 - 426
  • [5] The outcome of partial splenic embolization for hypersplenism in the cirrhotic patients
    Elmonem, Said A.
    Tantawy, Hazim I.
    Ragheb, Ahmad S.
    Matar, Nawel E. H.
    Tantawi, Ismail
    [J]. EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2011, 42 (01): : 35 - 42
  • [6] PARTIAL SPLENIC EMBOLIZATION FOR THE TREATMENT OF HYPERSPLENISM IN CIRRHOSIS
    SANGRO, B
    BILBAO, I
    HERRERO, I
    CORELLA, C
    LONGO, J
    BELOQUI, O
    RUIZ, J
    ZOZAYA, JM
    QUIROGA, J
    PRIETO, J
    [J]. HEPATOLOGY, 1993, 18 (02) : 309 - 314
  • [7] Effect of partial splenic embolization on the immune function of cirrhosis patients with hypersplenism
    Jin, Gui-Yun
    Lv, Chuan-Zhu
    Deng, Tang
    Chang, Shao-Wen
    Li, Chao-Qian
    [J]. ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2016, 9 (07) : 688 - 692
  • [8] Partial Splenic Artery Embolization for the Management of Hypersplenism in Cirrhosis
    Ramanan, Padmasani Venkat
    Krishna, Vidya
    [J]. INDIAN PEDIATRICS, 2015, 52 (08) : 718 - 719
  • [9] Effect of partial splenic embolization on the immune function of cirrhosis patients with hypersplenism
    Gui-Yun Jin
    Chuan-Zhu Lv
    Tang Deng
    Shao-Wen Cheng
    Chao-Qian Li
    [J]. Asian Pacific Journal of Tropical Medicine, 2016, 9 (07) : 688 - 692
  • [10] Role of partial splenic arterial embolization for hypersplenism in patients with liver cirrhosis and thrombocytopenia
    Abdella H.M.
    Abd-El-Moez A.T.
    Abu El-Maaty M.E.
    Helmy A.Z.
    [J]. Indian Journal of Gastroenterology, 2010, 29 (2) : 59 - 61